APA (7th ed.) Citation

R, H., E, J., A, K., J, L., J, P., P, B., . . . M, F. (2015). A novel RNA-based adjuvant combines strong immunostimulatory capacities with a favorable safety profile. International journal of cancer, 137(2), 372. https://doi.org/10.1002/ijc.29402

Chicago Style (17th ed.) Citation

R, Heidenreich, et al. "A Novel RNA-based Adjuvant Combines Strong Immunostimulatory Capacities with a Favorable Safety Profile." International Journal of Cancer 137, no. 2 (2015): 372. https://doi.org/10.1002/ijc.29402.

MLA (9th ed.) Citation

R, Heidenreich, et al. "A Novel RNA-based Adjuvant Combines Strong Immunostimulatory Capacities with a Favorable Safety Profile." International Journal of Cancer, vol. 137, no. 2, 2015, p. 372, https://doi.org/10.1002/ijc.29402.